Drug intelligence / Profile preview

RMF-004

Development stage
Preclinical
Lead developer
Cellontech
Modality
Recombinant Proteins and Enzymes, Cell Therapies
01

Overview

RMF-004 is a preclinical regenerative medicine formulation developed by Cellontech (formerly Sewon Cellontech) for the treatment of tendon and ligament injuries. As part of Cellontech's Regenerative Medical System (RMS) platform, RMF-004 (also known as RMS-Tendon) is designed as a combination therapy that utilizes autologous tenocytes delivered within a proprietary bio-collagen scaffold (atelocollagen). The formulation is intended for local administration at the site of injury, where the atelocollagen provides a biocompatible structural framework that mimics the natural extracellular matrix. This scaffold supports the adhesion, migration, and proliferation of the delivered tenocytes, facilitating the synthesis of new collagen fibers and the restoration of the mechanical and functional integrity of damaged connective tissues.

Other names
RMS-Tendon

Beyond the preview

Go deeper on RMF-004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RMF-004.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call